
Psychemedics Corporation PMD
Quartalsbericht 2024-Q3
hinzugefügt 12.11.2024
Psychemedics Corporation Operativer Cashflow 2011-2026 | PMD
Operativer Cashflow Jährlich Psychemedics Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.48 M | 4.89 M | 414 K | -4.08 M | 4.31 M | 7.93 M | 9.15 M | 9.27 M | 4.58 M | - | - | 3.09 M | 3.94 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 9.27 M | -4.08 M | 3.82 M |
Operativer Cashflow Vierteljährlich Psychemedics Corporation
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -473 K | - | - | - | -225 K | - | 3 M | 662 K | 345 K | - | -151 K | 237 K | -413 K | - | -5.22 M | -3.73 M | -413 K | - | 3.36 M | 1.69 M | 368 K | - | 4.01 M | 3.6 M | 1.41 M | - | 7.12 M | 3.43 M | 4.4 M | - | 6.07 M | - | - | - | - | - | - | - | - | - | - | - | - | - | 609 K | - | 2.48 M | 1.45 M | 167 K | - | 781 K | 854 K | -90.3 K |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.12 M | -5.22 M | 1.26 M |
Operativer Cashflow anderer Aktien in der Diagnostik & Forschung
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
1.48 B | $ 114.84 | -0.55 % | $ 34.9 B | ||
|
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | ||
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | ||
|
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | ||
|
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | ||
|
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | ||
|
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-7.17 M | $ 2.59 | 1.37 % | $ 84.1 K | ||
|
Biodesix
BDSX
|
-48.6 M | $ 15.32 | 1.66 % | $ 1.99 B | ||
|
Biomerica
BMRA
|
-3.84 M | $ 2.17 | - | $ 4.98 M | ||
|
BioNano Genomics
BNGO
|
-16.3 M | $ 1.19 | -1.25 % | $ 6.48 M | ||
|
Burning Rock Biotech Limited
BNR
|
-478 M | $ 16.57 | 2.28 % | $ 178 M | ||
|
CareDx, Inc
CDNA
|
42 M | $ 18.37 | 0.33 % | $ 979 M | ||
|
Celcuity
CELC
|
-153 M | $ 113.92 | 1.14 % | $ 5.33 B | ||
|
Co-Diagnostics
CODX
|
-29.1 M | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | ||
|
Charles River Laboratories International
CRL
|
738 M | $ 167.82 | -3.49 % | $ 8.32 B | ||
|
Castle Biosciences
CSTL
|
64.9 M | $ 24.95 | 0.44 % | $ 693 M | ||
|
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 198.98 | 0.92 % | $ 22.1 B | ||
|
Danaher Corporation
DHR
|
6.42 B | $ 191.91 | 0.41 % | $ 137 B | ||
|
DexCom
DXCM
|
1.44 B | $ 63.19 | 1.56 % | $ 24.7 B | ||
|
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | ||
|
Fulgent Genetics
FLGT
|
21.1 M | $ 16.66 | -0.95 % | $ 504 M | ||
|
Guardant Health
GH
|
-185 M | $ 90.61 | -3.44 % | $ 11.4 B | ||
|
ICON Public Limited Company
ICLR
|
1.29 B | $ 111.56 | -2.31 % | $ 9.2 B | ||
|
Interpace Biosciences
IDXG
|
5.83 M | $ 1.96 | 5.82 % | $ 8.67 M | ||
|
Illumina
ILMN
|
837 M | $ 128.04 | 0.52 % | $ 20.4 B | ||
|
IQVIA Holdings
IQV
|
2.65 B | $ 171.32 | -1.12 % | $ 29.4 B | ||
|
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 275.75 | 0.74 % | $ 22.9 B | ||
|
Lantheus Holdings
LNTH
|
390 M | $ 76.36 | 0.35 % | $ 5.15 B | ||
|
Medpace Holdings
MEDP
|
713 M | $ 490.0 | -1.67 % | $ 14.1 B | ||
|
Organovo Holdings
ONVO
|
-9.46 M | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
-4.87 M | - | -16.95 % | $ 1.54 M | ||
|
Mettler-Toledo International
MTD
|
956 M | $ 1 257.33 | -0.21 % | $ 25.9 B | ||
|
Myriad Genetics
MYGN
|
1.8 M | $ 4.78 | 0.63 % | $ 443 M | ||
|
ENDRA Life Sciences
NDRA
|
-5.18 M | $ 4.51 | -3.84 % | $ 3.55 M | ||
|
NeoGenomics
NEO
|
5.23 M | $ 8.0 | - | $ 1.02 B |